Traumatic brain injury (TBI) test
K223602 is the FDA 510(k) clearance record for Traumatic brain injury (TBI) test, a class II device, cleared for Abbott Laboratories on under FDA product code QAT (Brain Trauma Assessment Test). FDA's definition for product code QAT reads: "Intended for in vitro diagnostic use as an aid in the evaluation of patients with suspected mild traumatic brain injury (TBI) in conjunction with other clinical information to assist in determining the need for radiologic (e.g., CT, MR)...". FDA records list 1,478 510(k) clearances for Abbott Medical, from to . As of , FDA records show no recalls naming K223602.
Clearance record
- Decision date
- Received
- (90 days to decision)
- Product code
- QAT Brain Trauma Assessment Test
- Regulation
- 21 CFR 866.5830
- Device class
- Class II
- Review panel
- Immunology
- Applicant
- Abbott Laboratories 100 Abbott Park Rd., Abbott Park IL
- 510(k) summary
- Summary PDF
- Third party review
- No
Clearances, product code QAT
Trailing 12 monthsFDA records hold no clearances under product code QAT in the trailing twelve months.
Show the numbers
| Month | Clearances |
|---|---|
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 0 |
| March 2026 | 0 |
| April 2026 | 0 |
| May 2026 | 0 |
| June 2026 | 0 |
| July 2026 | 0 |
| August 2026 | 0 |
| September 2026 | 0 |
| October 2026 | 0 |
FIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
